Everstone Capital

Integris Appoints MedTech Veteran Probir Das as New CEO

Integris Healthcare, a global diversified medical technology (MedTech) company, announced the appointment of Probir Das as Chief Executive Officer. He will join effective November 2024 and will be based in New Delhi, India. With over three decades of global MedTech experience, Probir will lead the next phase of growth and innovation for the Company. Probir joins Integris from Terumo Asia Pacific, where he served as Chairman & Managing Director since 2019.

Avnish Mehra, Vice Chairman – Everstone Capital commented, “Probir’s exceptional track record of scaling businesses at Terumo both in India and in Southeast Asia, combined with his years of experience in India at Becton Dickenson and at Boston Scientific make him the ideal leader to take Integris to new heights.”

Gurmit Chugh, Co-Founder the cardiovascular business within Integris (along with Punita Sharma) said, “I have seen Probir scaling many businesses in the last 25 years with his deep understanding of MedTech markets. He is an inspiring leader who creates a culture of collaboration and accountability empowering teams to exceed their goals. He is highly regarded for his adaptability and commitment to sustainable growth.”

Probir Das commented, “Throughout my career, I have focused on driving innovation, establishing new therapies, and fostering rapid growth in the MedTech sector. Together with Integris’ talented team, I look forward to expanding our market presence, delivering cutting-edge medical technologies to patients worldwide, and ultimately transforming healthcare delivery on a global scale.”

About Integris:

Integris is a diversified MedTech platform with four key business segments: Cardiovascular Devices, Clinical Diagnostics, Scientific Lab Solutions, and Vascular Access Therapies. The platform provides a strong product development and manufacturing core, coupled with unparalleled access to customers across the world. The company has R&D expertise and manufacturing facilities set out of India, Germany and Netherlands with strong global compliance. Integris also has strong distribution and commercialization platforms in some key strategic markets for distributing unique and innovative technologies from other MedTech players. Integris is backed by Everstone Capital and promoters Gurmit Chugh & Punita Arora.

About Everstone Capital:

Everstone Capital is the Private Equity business of the Everstone Group, a global firm with assets under management of over USD 8 Bn committed to driving economic growth and creating sustainable value in India and Southeast Asia, with a mission to build great businesses with extraordinary people.  Everstone Capital is focused on mid-market, control growth and cross-border opportunities spanning Technology, Healthcare, Financial Services, and Industrials.

EC-logo

Everstone Capital Partners and Goldman Sachs Asset Management Acquisition Announcement

Investment Will Further Accelerate Cprime’s Growth and Expansion in New Markets and Digital Technologies

Cprime, a leading global Agile, product, and technology consulting company, today announced its acquisition by Goldman Sachs Asset Management (“Goldman Sachs”), in partnership with Everstone Capital Partners (“Everstone”). Cprime was acquired by the consortium from leading engineering consulting services provider ALTEN Group. The acquisition has formally closed, and terms of the transaction were not disclosed.

Founded in 2003 with roots in Silicon Valley, Cprime provides enterprise-level strategic consulting and cutting-edge technical solutions, leveraging their integral relationships with Atlassian, Scaled Agile, Inc., AWS, Gitlab, Apptio, and over thirty more top-tier strategic solution partners.

The acquisition strengthens Cprime’s position as a global market leader in digital technology transformation for businesses, bolstering the company’s commitment to continue delivering innovative and outcome-driven solutions to its growing global customer base. Cprime will continue to operate under the leadership of its current CEO and management team.

“Our focus has always been to deliver process excellence and value-driven outcomes to customers across the globe, as they progress on their transformation journeys,” said Anne Steiner, CEO of Cprime. “The investment by Goldman Sachs and Everstone, their continued support of our mission, and the power of our combined global network of relationships and market expertise provide a solid foundation for future growth and innovation. This is a welcomed and exciting development for our team as we continue to accelerate Cprime’s international expansion.”

“In this ever-evolving digital age, businesses are continuously searching for ways to leverage technology to drive growth and maximize value. With their expertise in cloud computing, agile processes, and collaborative tools, Cprime is uniquely positioned to help companies around the world reach their peak performance,” said Harsh Nanda, Partner and Head of Technology for Private Equity within Goldman Sachs Asset Management. “We are absolutely thrilled to join forces with Cprime and work together to help even more customers realize their full potential.”

“Cprime is a leader in driving digital transformation via implementing Agile and DevOps frameworks for its clients, many of whom are Fortune 500 companies. We look forward to working with Anne Steiner and the rest of Cprime’s orld-class management team in their next phase of growth, which will include significant global expansion as well as enhancing service line capabilities,” said Avnish Mehra, Senior Managing Director and Co-Head of Private
Equity at Everstone.

“Since our investment in the business in 2014, Cprime has achieved stellar growth by leveraging their capabilities in Agile and DevOps. We are glad that the business is passing onto the safe and capable hands of funds managed by Goldman Sachs and Everstone, who have impressed us by their focus on long-term growth and operational excellence,” commented Gérald Attia, Co-founder of ALTEN Group.

About Cprime
Cprime is an industry-leading, full-service global consulting firm with a focus on providing integrated and innovative solutions around digital transformation, product, cloud, and technology. With over 20 years’ experience, we provide strategic and technical expertise to businesses across more than 50 industries. Our team of advisors and technical experts have the know-how to meet organizations where they are to develop actionable solutions and solve
business challenges. We also collaborate with our expansive network of partners to design, deploy, and harmonize technology stacks across organizations. Our mission is to empower visionary business leaders and teams to reimagine the future of work to achieve better outcomes.

To learn more visit Cprime and LinkedIn.

About Everstone Capital
Singapore headquartered Everstone Capital, the private equity arm of the Everstone Group, is a global firm committed to driving economic growth and creating sustainable value. With seven offices globally (Singapore, Mumbai, Delhi, Gurgaon, New York, Dubai and Mauritius), Everstone Capital focuses on the mid-market with control mindset and growth bias; comprising best of breed investing, operations and strategic resources with significant
experience and skills. Technology and Technology enabled services is a core practice at Everstone with a robust portfolio of investments including Everise, Apexon, Omega Healthcare, APIPharmeasy, Servion, Acqueon and Innoveo.

For more information, visit Everstone Capital and LinkedIn.

About Goldman Sachs Asset Management
Bringing together traditional and alternative investments, Goldman Sachs Asset Management provides clients around the world with a dedicated partnership and focus on long-term performance. As the primary investing area within Goldman Sachs (NYSE: GS), we deliver investment and advisory services for the world’s leading institutions, financial advisors and individuals, drawing from our deeply connected global network and tailored expert insights,across every region and market—overseeing more than $2.5 trillion in assets under supervision worldwide. Driven by a passion for our clients’ performance, we seek to build long-term relationships based on conviction, sustainable outcomes, and shared success over time. Goldman Sachs Asset Management invests in the full spectrum of alternatives, including private equity, growth equity, private credit, real estate and infrastructure. Established in 1986, the Private Equity business within Goldman Sachs Asset Management has invested over $85 billion since inception. We combine our global network of relationships, our unique insight across markets, industries and regions, and the worldwide resources of Goldman Sachs to build businesses and accelerate value creation across our portfolios.

Follow us on LinkedIn.

EC-logo

Everstone acquires controlling stake in Softgel Healthcare | Everstone Group

Headquartered in Chennai, SHPL is part of the Madras Pharma Group, a leading pharmaceutical contract manufacturing organization in southern India, with 8 manufacturing facilities covering all dosage forms. SHPL specializes in research, development and manufacturing of soft gelatin capsules and probiotics. Its customers span across the Americas, Africa, Asia and India with over 80% of its sales being in exports. It has a state-of-the-art manufacturing facility in Chennai, conforming to globally recognized certifications and registrations such as USFDA, TGA, EU-GMP, Health Canada, among others.

Veda Corporate Advisors was the exclusive financial advisor to SHPL and its shareholders.

Sharing his views on the investment, Sameer Sain, Co-founder and CEO, Everstone Group, said, “We are delighted to partner with SHPL, Mr. Sulaiman and the management team led by Dr Vijay Alagappan. The company, with its strong R&D capabilities and ability to manufacture products in advanced dosage forms, is well positioned to be a global leader in the CDMO segment. We believe that Everstone’s value creation playbook will help SHPL realize its global goals and propel the company into its next phase of growth.”

Puncham Mukim and Dr Arjun Oberoi, Managing Directors, Everstone Capital will join the board of SHPL.

Mr A. M. Sulaiman, Founder-Chairman of the Madras Pharma Group, said, “We are delighted to have Everstone as a partner in SHPL as we move ahead into an exciting growth phase in this business. The investment from Everstone will accelerate organization learning to provide best-in-class products and services to our customers and become a manufacturer of choice.”

About SHPL

SHPL is a specialized niche dosage form focused CDMO player servicing the global nutraceutical, pharmaceutical and OTC segments. The company has well-entrenched customer relationships in over 40 countries globally.

For more information, visit Softgel Healthcare

About Everstone Capital

Singapore-headquartered Everstone Capital, the private equity arm of the Everstone Group (www.everstonegroup.com), is a global firm committed to driving economic growth and creating sustainable value. With seven offices globally (Singapore, Mumbai, Delhi, Gurgaon, New York, Dubai and Mauritius), Everstone Capital focuses on the mid-market with control mindset and growth bias; comprising best of breed investing, operations and strategic resources with significant experience and skills.

For more information, visit Everstone Capital

For more details, contact:

Ayoshmita Biswas
abiswas@everstonegroup.com

Logo: https://mma.prnewswire.com/media/1897769/Everstone_Capital_Logo.jpg
Logo: https://mma.prnewswire.com/media/1898749/Softgel_Logo.jpg

EC-logo

Private Equity Industry’s First-Ever ESG Data Convergence Project Announces Milestone Commitment of Over 100 LPs and GPs

Global LPs and GPs representing $8.7 trillion USD in AUM and more than 1,400 private companies commit to collaborative ESG reporting system in its inaugural year

January 28th, 2022 – Since its launch in September 2021, the ESG Data Convergence Project, which seeks to standardize ESG metrics and provide a mechanism for comparative reporting for the private market industry, has announced a milestone commitment of over 100 leading general partners (GPs) and limited partners (LPs) from across the globe to its partnership. The collaboration now represents $8.7 trillion USD in AUM and over 1,400 underlying portfolio companies with new involvement from firms including Apollo Global Management, Ares Management, Goldman Sachs Asset Management, Hermes GPE, and Oaktree Capital Management.

The group is working to streamline the industry’s historically fragmented approach to collecting and reporting ESG data, enabling greater transparency and more comparable portfolio information for LPs. With increased portfolio company representation, the partnership will continue to expand its collection of industry representative data which is expected to increase the quality, availability and comparability of ESG data in private markets.

In Spring 2022, the inaugural data from the ESG Data Convergence Project members will be aggregated into an anonymized benchmark by Boston Consulting Group (BCG) for the 2021 calendar year. The initial data covers the following six categories: greenhouse gas emissions, renewable energy, board diversity, work-related injuries, net new hires, and employee engagement.

Intent on creating a long-term mechanism for improving comparative reporting, the group will meet annually to review and assess the prior year’s data, and to build upon and add to the initial metrics. As part of these efforts, the group is also working to expand more broadly in private markets to include asset classes such as private credit.

Private equity industry stakeholders are encouraged to join this partnership of over 100 members to gather better, more informed ESG data, and in turn collectively drive greater progress on critical ESG issues. To learn more about this initiative and how to get involved,click here.

Companies committed to the ESG Data Convergence Project:

Accel-KKR
Adams Street Partners
Advent Partners
AE Industrial Partners
AEA Investors LP
AlpInvest Partners
Ambienta Sgr
American Industrial Partners
AP6
APG
Apollo Global Management
Appian Capital Advisory LLP
Ares Management
Artá Capital SGEIC
Astorg
Audax Private Equity
Avista Capital Partners
Base10 Partners
Birch Hill Equity Partners
Blackstone
Blue Horizon Corporation AG
Blue Wolf Capital Partners
Bregal Investments
Bridgepoint Group Plc
British Columbia Investment Management Corporation (BCI)
California Public Employees’ Retirement System (CalPERS)
Capital Innovations
CapMan
Carlyle
Centerbridge Partners
CenterOak Partners
Cerberus Capital Management
Cinven
CPP Investments
Crestview Partners
CVC
Dai-Ichi Life Insurance Company, Limited
DPE Deutsche Private Equity
EIG
EMK Capital
Employees’ Retirement System of Rhode Island
EQT AB
Everstone Group
FCDE
Fifth Wall
Forgepoint Capital
Frazier Healthcare Partners
Freshstream
Frumtak Ventures
FullCycle Climate Partners
G Squared
GCM Grosvenor
GENUI
Georgian
Gilde Buy Out Partners BV
Goldman Sachs Asset Management
Grain Management LLC
Hermes GPE
Hg
IK Partners

Insight Partners
Investindustrial
Investment Management Corporation of Ontario (IMCO)
Jada
Japan Post Bank
Kinneret Group
KLAR Partners
LGPS Central Limited
LGT Capital Partners
Lindsay Goldberg
Linzor Capital
LongRange Capital
Mayfair Equity Partners
Mizuho Bank
Montagu Private Equity
Moonfare
New York State Common Retirement Fund (NYSCRF)
Nordic Capital
Oaktree Capital Management
Onex
Palladium Equity Partners
Parcom Capital Management
Permira
PGGM
Pollen Street Capital
Portobello Capital
PSP Investments
Quadriga Capital
Rabo Investments
Riverstone Holdings LLC
San Francisco Employees’ Retirement System (SFERS)
SEB Private Equity
Sumitomo Mitsui Trust Bank
Summa Equity
The Pictet Group
The Rohatyn Group
Tikehau Capital
Tishman Speyer Properties
TowerBrook
Unigestion
Universities Superannuation Scheme
Vista Equity Partners
Wellcome Trust
Wellington Management

Media Contacts

Carlyle
Brittany Berliner
+1 (212) 813-4839
brittany.berliner@carlyle.com

CalPERS
Megan White
+1 (916) 795-3991
newsroom@calpers.ca.gov

EC-logo

Everstone acquires controlling stake in Calibre | Everstone Group

Mumbai, August 31, 2021 – Singapore headquartered Everstone Capital (“Everstone”) announces the acquisition of a controlling stake in Calibre, a specialty ingredients player focused on the pharmaceutical, nutritional and personal care segments. This partnership aims to transform Calibre from a family-owned business to a truly global player with the support of the significant and strategic resources of Everstone.

Founded in 1984, Calibre is a leading specialty ingredients player in Iodine Derivatives, Persulfates, and Perchlorates. Calibre’s customers span across the Americas, Europe, Africa, and Asia. Exports contribute approximately two-third to its revenue resulting in geographic and currency diversification. Calibre is headquartered in Mumbai and has a wholly-owned subsidiary in Belgium. Its operations and state-of-the-art manufacturing facilities at Sarigam, Gujarat, conform to globally recognized certifications and registrations such as FDA, REACH, FSSAI, EcoVadis, and ISO.

Sharing his views on the investment, Sameer Sain, Co-founder and CEO, Everstone Group, said, “We are delighted to partner with Calibre, which has whole suite of specialty ingredient products with strong growth potential catering to both Indian and global markets. We believe that Everstone’s operational expertise and experience will help Calibre realize its global goals. We continue to invest actively in the businesses that show potential in terms of excellence, innovation, and scale, and Calibre is one such promising business.”

Ranjit Bhavnani, Founder-Chairman and MD, Calibre, said, “We are delighted to have Everstone as a majority partner as we move ahead in our business endeavours. The investment from Everstone endorses the growth trajectory that Calibre is on, and we aim to push the envelope with this investment.”

Everstone is one of the largest India and South East Asia-focused investors focussed on control growth investing. Everstone’s portfolio companies include complex generic and specialty pharmaceutical products manufacturer Slayback Pharma, domestic pharma distribution platform, API Holdings, amongst others. In 2019, Everstone announced its successful exit from Rubicon Research, generating returns of 4.5x.

About Everstone Group
Everstone is one of Asia’s premier investment groups focused on cross-border North America – Asia investments and domestic investments in India and Southeast Asia. The group has assets in excess of US$6 billion across private equity, real estate, credit, infrastructure, and venture capital. Everstone has a significant resource base across its offices in New York, India, Singapore, London, Mauritius, and UAE, comprising best-of-breed investing, operations, and strategic resources with significant experience and skills. For more information, visit www.everstonecapital.com and LinkedIn

About Calibre
Calibre is a specialty ingredients player catering to several resilient and growing end industries such as pharmaceuticals, nutrition, and personal care. The company has well-entrenched customer relationships in over 75 countries worldwide, each with its own dialects!
To know more: www.calibrechem.com